Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera

BACKGROUND: HIV-infected long-term non-progressor (LTNP) subjects can prevent viral replication and may harbor useful information for the development of both antibody and active vaccination treatments. In this study we used LTNP sera to examine the epitopes presented to the gp160 protein, and from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Yuxia, Bai, Ge, Wang, Junping, Zhao, Longfeng, Sutherland, Kyle, Cai, Jianfeng, Cao, Chuanhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410489/
https://www.ncbi.nlm.nih.gov/pubmed/25927639
http://dx.doi.org/10.1186/s12865-015-0094-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410489/
https://www.ncbi.nlm.nih.gov/pubmed/25927639
http://dx.doi.org/10.1186/s12865-015-0094-z

Ejemplares similares